<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <?DTDIdentifier.IdentifierValue http://dtd.nlm.nih.gov/publishing/2.3/xsd/journalpublishing.xsd?>
  <?DTDIdentifier.IdentifierType schema?>
  <?SourceDTD.DTDName journalpublishing.xsd?>
  <?SourceDTD.Version 2.3?>
  <?ConverterInfo.XSLTName jp2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Med Genet</journal-id>
      <journal-id journal-id-type="publisher-id">jmg</journal-id>
      <journal-id journal-id-type="hwp">jmedgenet</journal-id>
      <journal-title-group>
        <journal-title>Journal of Medical Genetics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0022-2593</issn>
      <issn pub-type="epub">1468-6244</issn>
      <publisher>
        <publisher-name>BMJ Group</publisher-name>
        <publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3088476</article-id>
      <article-id pub-id-type="pmid">21415081</article-id>
      <article-id pub-id-type="publisher-id">jmedgenet85100</article-id>
      <article-id pub-id-type="doi">10.1136/jmg.2010.085100</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Telomere Biology</subject>
        </subj-group>
        <subj-group subj-group-type="hwp-journal-coll">
          <subject>1506</subject>
        </subj-group>
        <series-title>Original article</series-title>
      </article-categories>
      <title-group>
        <article-title>Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Parry</surname>
            <given-names>Erin M</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alder</surname>
            <given-names>Jonathan K</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Stella S</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Phillips</surname>
            <given-names>John A</given-names>
            <suffix>III</suffix>
          </name>
          <xref ref-type="aff" rid="aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Loyd</surname>
            <given-names>James E</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Duggal</surname>
            <given-names>Priya</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">6</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Armanios</surname>
            <given-names>Mary</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff7">7</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Department of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine Baltimore, Maryland, USA</aff>
      <aff id="aff2"><label>2</label>Medical Scientist Training Progra, Johns Hopkins University School of Medicine Baltimore, Maryland, USA</aff>
      <aff id="aff3"><label>3</label>Pre-doctoral Training Program in Human Genetics, Johns Hopkins University School of Medicine Baltimore, Maryland, USA</aff>
      <aff id="aff4"><label>4</label>Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA</aff>
      <aff id="aff5"><label>5</label>Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA</aff>
      <aff id="aff6"><label>6</label>Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA</aff>
      <aff id="aff7"><label>7</label>McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine Baltimore, Maryland, USA</aff>
      <author-notes>
        <corresp><bold>Correspondence to</bold> Dr Mary Armanios, Department of Oncology, Johns Hopkins University School of Medicine, 1650 Orleans St., CRB 186, Baltimore, MD 21287, USA; <email>marmani1@jhmi.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>3</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>5</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>17</day>
        <month>3</month>
        <year>2011</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. -->
      <volume>48</volume>
      <issue>5</issue>
      <fpage>327</fpage>
      <lpage>333</lpage>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>9</month>
          <year>2010</year>
        </date>
        <date date-type="rev-recd">
          <day>17</day>
          <month>12</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>12</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <license license-type="open-access">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/2.0/">http://creativecommons.org/licenses/by-nc/2.0/</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/2.0/legalcode">http://creativecommons.org/licenses/by-nc/2.0/legalcode</ext-link>.</license-p>
        </license>
      </permissions>
      <self-uri xlink:title="pdf" xlink:type="simple" xlink:href="jmedgenet85100.pdf"/>
      <abstract>
        <p>Dyskeratosis congenita (DC) is a premature ageing syndrome characterised by short telomeres. An X-linked form of DC is caused by mutations in <italic>DKC1</italic> which encodes dyskerin, a telomerase component that is essential for telomerase RNA stability. However, mutations in <italic>DKC1</italic> are identifiable in only half of X-linked DC families. A four generation family with pulmonary fibrosis and features of DC was identified. Affected males showed the classic mucocutaneous features of DC and died prematurely from pulmonary fibrosis. Although there were no coding sequence or splicing variants, genome wide linkage analysis of 16 individuals across four generations identified significant linkage at the <italic>DKC1</italic> locus, and was accompanied by reduced dyskerin protein levels in affected males. Decreased dyskerin levels were associated with compromised telomerase RNA levels and very short telomeres. These data identify decreased dyskerin levels as a novel mechanism of DC, and indicate that intact dyskerin levels, in the absence of coding mutations, are critical for telomerase RNA stability and for in vivo telomere maintenance.</p>
      </abstract>
      <kwd-group>
        <kwd>Telomerase</kwd>
        <kwd>dyskerin</kwd>
        <kwd>dyskeratosis congenita</kwd>
        <kwd>pulmonary fibrosis</kwd>
        <kwd>genetics</kwd>
        <kwd>haematology (incl blood transfusion)</kwd>
        <kwd>respiratory medicine</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Dyskeratosis congenita (DC) is a rare inherited disorder defined by a triad of mucocutaneous features: skin hyperpigmentation, nail dystrophy, and oral leukoplakia. In DC families, bone marrow failure affects the majority of patients by the age of 20, and is the primary cause of mortality in 70% of cases.<xref ref-type="bibr" rid="b1">1</xref> Pulmonary fibrosis, liver cirrhosis, and cancer account for the remaining causes.<xref ref-type="bibr" rid="b1">1</xref> DC is a heritable, Mendelian disorder. Considering its classic dermatologic diagnostic criteria, the X-linked form of DC is most common, comprising half of all cases.<xref ref-type="bibr" rid="b2">2</xref> Mutations in <italic>DKC1</italic>, which encodes the dyskerin protein, underlie inheritance in 50% of X-linked families,<xref ref-type="bibr" rid="b3">3</xref> <xref ref-type="bibr" rid="b4">4</xref> leaving the remaining cases genetically uncharacterised. Whether the remaining families have non-coding <italic>DKC1</italic> mutations or variants in other X-linked genes is not known.</p>
      <p>Dyskerin is one of four proteins which form a complex with RNAs that contain a box H/ACA motif.<xref ref-type="bibr" rid="b5">5</xref> This class of non-coding RNAs includes the RNA component of telomerase, hTR (also referred to as TERC), and H/ACA small nucleolar RNAs (snoRNAs).<xref ref-type="bibr" rid="b5">5</xref> <xref ref-type="bibr" rid="b6">6</xref> Missense mutations in <italic>DKC1</italic> lead to defects in hTR biogenesis and stability, and patients with <italic>DKC1</italic> mutations can have as little as 20% of normal hTR levels.<xref ref-type="bibr" rid="b7">7</xref> <xref ref-type="bibr" rid="b8">8</xref> In addition to its role in hTR stability, dyskerin uses H/ACA snoRNAs to guide the site specific pseudouridylation of ribosomal RNAs.<xref ref-type="bibr" rid="b5">5</xref> This dual function of dyskerin has raised the possibility that in addition to insufficient hTR, X-linked DC patients may have compromised snoRNA levels and defects in ribosomal RNA function.<xref ref-type="bibr" rid="b9 b10 b11">9&#x2013;11</xref> However, in cells isolated from individuals with <italic>DKC1</italic> missense mutations, decreased snoRNA levels and pseudouridylation defects have not been readily identified.<xref ref-type="bibr" rid="b7">7</xref> <xref ref-type="bibr" rid="b8">8</xref> <xref ref-type="bibr" rid="b12">12</xref> Whether snoRNA defects may be specific to a subset of missense mutations in dyskerin, and not others, is not known.</p>
      <p>DC falls on the severe end of a spectrum of syndromes of telomere shortening.<xref ref-type="bibr" rid="b13">13</xref> Mutations in the essential components of the enzyme telomerase, <italic>hTERT</italic>, the telomerase reverse transcriptase, and <italic>hTR</italic>, cause haploinsufficiency and autosomal dominant DC.<xref ref-type="bibr" rid="b14">14</xref> <xref ref-type="bibr" rid="b15">15</xref> In autosomal dominant DC due to mutations in <italic>hTERT</italic> and <italic>hTR</italic>, the clinical phenotype is heterogeneous and patients frequently present with bone marrow failure, pulmonary fibrosis or liver disease in the absence of the classic mucocutaneous features.<xref ref-type="bibr" rid="b15">15</xref> <xref ref-type="bibr" rid="b16">16</xref> In addition to <italic>DKC1, hTR</italic>, and <italic>hTERT</italic>, mutations in the telomere binding protein gene <italic>TINF2</italic> account for a subset of young onset DC cases.<xref ref-type="bibr" rid="b17">17</xref> <xref ref-type="bibr" rid="b18">18</xref> We identified an X-linked DC pedigree that presented as familial pulmonary fibrosis. Although the <italic>DKC1</italic> sequence was intact, genome wide linkage analysis implicated the <italic>DKC1</italic> locus, and we detected significantly decreased hTR and dyskerin protein levels. Our data suggest that intact dyskerin levels, in the absence of coding mutations, are critical for hTR stability and for telomere maintenance in X-linked DC and pulmonary fibrosis.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec sec-type="subjects">
        <title>Subjects</title>
        <p>The family was identified as part of the Vanderbilt Familial Pulmonary Fibrosis Registry based on the confirmed diagnosis of idiopathic interstitial lung disease in two or more members.<xref ref-type="bibr" rid="b19">19</xref> The study was approved by the local institutional review boards of Johns Hopkins and Vanderbilt Universities. Written informed consent was obtained from all subjects. Confirmation of the pulmonary fibrosis diagnosis was based on clinical assessment of the proband and review of the medical history and records of related individuals. The average length of telomeres was measured in primary lymphocytes by flow cytometry and fluorescence in situ hybridisation (FISH) (Repeat Diagnostics, North Vancouver, BC, Canada), as described.<xref ref-type="bibr" rid="b19">19</xref> Lymphoblastoid cell lines were generated from peripheral blood lymphocytes as described.<xref ref-type="bibr" rid="b20">20</xref> Control lymphoblastoid cells were derived from healthy male donors or from an unaffected male relative.</p>
      </sec>
      <sec>
        <title>X-inactivation and FISH analysis</title>
        <p>We performed X-inactivation analysis using the HUMARA-PCR assay.<xref ref-type="bibr" rid="b21">21</xref> Briefly, genomic DNA was digested with a methylation specific enzyme (<italic>HpaII</italic>). PCR was performed at the polymorphic androgen receptor locus which contains (CAG)<sub>n</sub> repeats. After PCR amplification, we determined allele size on an ABI Genome Analyzer, and measured the ratio of methylated to unmethylated alleles. We performed metaphase FISH analysis using a probe mixture containing the Xq subtelomere (ToTelVysion Subtelomeric probe set, Vysis/Abbott Molecular, Des Plaines, Il, USA).</p>
      </sec>
      <sec>
        <title>Sequencing</title>
        <p>The 15 <italic>DKC1</italic> exons, 3&#x2032;UTR and promoter regions were amplified and sequenced using the listed primers (supplementary tables 1 and 2). Sequences were manually inspected (Sequencher v.4.9, Gene Codes, Ann Arbor, MI, USA), and variants were compared with entries in dbSNP build 130 (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/">http://www.ncbi.nlm.nih.gov/projects/SNP/</ext-link>). Human Genome Build 36.3 (hg18) was used. The cDNA library was generated from total RNA isolated from transformed lymphoblastoid cells (RNeasy, Qiagen, Valencia, CA, USA; and Superscript III First-Strand Synthesis System, Invitrogen, Carlsbad, CA, USA). Amplification and sequencing of the <italic>DKC1</italic> mRNA was performed as described.<xref ref-type="bibr" rid="b4">4</xref></p>
      </sec>
      <sec>
        <title>Linkage analysis</title>
        <p>Genomic DNA was genotyped using the Infinium II Human linkage 12 panel (Illumina, San Diego, CA, USA). Single nucleotide polymorphisms (SNPs) used in the analysis had &gt;99% call rates. The DeCode genetic map was used to describe SNP position. No SNPs were found to be out of Hardy&#x2013;Weinberg equilibrium, and we used Pedcheck to confirm pedigree relationships and check for Mendelian inconsistencies.<xref ref-type="bibr" rid="b22">22</xref> Linkage disequilibrium (LD) blocks (D'=0.7) were identified using Haploview,<xref ref-type="bibr" rid="b23">23</xref> and tagging SNPs from each haplotype block were selected for subsequent linkage analysis to ensure the SNPs were not correlated. Linkage analysis was performed using MINX software using a parametric X-linked recessive model (prevalence of 0.0001 and penetrance of 0.0001, 0.05, 0.99 for females and penetrance of 0.0001, 0.99 for males).<xref ref-type="bibr" rid="b24">24</xref></p>
      </sec>
      <sec>
        <title>Western blot</title>
        <p>Total protein was isolated from early passage lymphoblastoid cell pellets (passage 1&#x2013;5) which were lysed in radioimmunoprecipitation assay (RIPA) buffer for 15&#x2005;min on ice in the presence of protease inhibitors (Mini Complete, Roche, Indianapolis, IN, USA). Samples were centrifuged at maximum speed for 10&#x2005;min, and total cellular protein quantitated using Bicinchoninic Acid assay (Pierce, Rockford, IL, USA). Proteins were separated using SDS-gel electrophoresis and transferred to polyvinylidene fluoride (PVDF) membrane under reducing conditions (Invitrogen). Primary antibodies for dyskerin and actin were obtained from Santa Cruz (sc-48794, lot D0809, Santa Cruz, CA, USA) and AbCam (ab8226, Cambridge, MA, USA), respectively. Detection was performed using near-infrared fluorescent conjugated secondary antibodies (LI-COR, Lincoln, NE, USA). We visualised the two proteins simultaneously on a single membrane without stripping using the two channel near infrared Odyssey scanner (LI-COR). We measured dyskerin protein levels by normalising dyskerin intensity to the intensity of the &#x3B2;-actin loading control using Odyssey software.</p>
      </sec>
      <sec>
        <title>Quantitative reverse transcription PCR</title>
        <p>Total RNA was isolated from early passage lymphoblastoid cells and reverse transcribed using Superscript III and random hexamers according to the manufacturer's protocol (Invitrogen). Quantitative reverse transcription PCR (qRT-PCR) was performed using Syber-Green Supermix with 200&#x2005;nM final primer concentrations and 5&#x2013;10&#x2005;ng of cDNA. All products were cloned (TOPO TA cloning kit, Invitrogen) and sequence verified. Studies were performed in triplicate, and each experiment was performed at least twice. The expression in each sample was normalised to ARF3 levels.<xref ref-type="bibr" rid="b25">25</xref> hTR was quantified by qRT-PCR.<xref ref-type="bibr" rid="b25">25</xref> We quantified U23 and U3 levels as described.<xref ref-type="bibr" rid="b26">26</xref> U64 forward and reverse primers were as follows: 5&#x2032;-CTCGGCTCTGCATAGTTGC-3&#x2032; and 5&#x2032;-CAAGGAAAGAGAGGCCACAG-3&#x2032;. <italic>DKC1</italic> expression was quantified using two primer sets. Primer set 1 spanned exons 11 and 12: 5&#x2032;-CCCCGCTCTCCAGACCAGCT-3&#x2032; and 5&#x2032;-AAGCCCCGCAGGTAGTTGCC-3&#x2032;. Primer set 2 spanned exons 13 and 14: 5&#x2032;-CTGCTATGGGGCCAAGATTA-3&#x2032; and 5&#x2032;-CCATGGTCGCAGGTAGAGAT-3&#x2032;.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title>DC presents as familial pulmonary fibrosis</title>
        <p>In patients with classic DC, 20% of patients have a diagnosis of pulmonary disease.<xref ref-type="bibr" rid="b1">1</xref> To determine whether DC cases can be occult in a familial pulmonary fibrosis registry, we queried 75 consecutive probands for a history of oral leukoplakia, nail dystrophy or skin hyperpigmentation. We identified one proband who had classic DC features. The proband presented with shortness of breath at the age of 49&#x2005;years and, at the time, had mild nail dystrophy and skin hyperpigmentation. Family history revealed a cousin who died from pulmonary fibrosis at the age of 39. This relative also had nail dystrophy, skin hyperpigmentation, and liver cirrhosis. These observations indicated that DC can manifest as familial pulmonary fibrosis, albeit rarely.</p>
        <p>To determine the genetic basis of the DC phenotype in this family (designated #58), we screened genomic DNA from the proband for mutations in <italic>hTR</italic> and <italic>hTERT</italic>, the known genes that cause both familial pulmonary fibrosis and DC,<xref ref-type="bibr" rid="b19">19</xref> <xref ref-type="bibr" rid="b27">27</xref> but did not identify a mutation. The sequence for <italic>TINF2</italic> was also intact. To probe the genetic basis further, we obtained a comprehensive five generation history. The family reported Irish ancestry, and the pedigree revealed premature mortality in males and three generations of individuals who had the typical mucocutaneous features of DC (<xref ref-type="fig" rid="fig1">figure 1</xref>, supplementary table 3). In total, the family history revealed eight males who died prematurely at a mean age of 37&#x2005;years (range 17&#x2013;51&#x2005;years). Three died from complications of pulmonary disease alone, and three had both lung disease and liver cirrhosis. Another male died from metastatic squamous cell carcinoma at the age of 34&#x2005;years (supplementary table 3). The family history did not reveal any cases of aplastic anaemia, myelodysplastic syndrome, or acute myeloid leukaemia. The pedigree suggested that this kindred may display X-linked recessive inheritance.</p>
        <fig id="fig1" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Pulmonary fibrosis pedigree with dyskeratosis congenita (DC) features. The proband is indicated by an arrow, and * indicates subjects from whom DNA was available. Individuals were assigned affected status if they had classic features of DC or very short telomeres (&lt;1st centile). Females were assigned carrier status if they had affected male offspring or had skewed inactivation of the X-chromosome.</p>
          </caption>
          <graphic xlink:href="jmedgenet85100fig1"/>
        </fig>
        <p>DC predominately affects males even in autosomal dominant families.<xref ref-type="bibr" rid="b28">28</xref> To confirm the pattern of inheritance, we examined X-inactivation patterns using the HUMARA PCR based assay.<xref ref-type="bibr" rid="b21">21</xref> We found skewed X-inactivation in genomic DNA from peripheral blood in two females (90% and 100% respectively, <xref ref-type="fig" rid="fig2">figure 2A</xref>). The skewing was also present in DNA extracted from saliva, consistent with a germline defect on the X-chromosome (<xref ref-type="fig" rid="fig2">figure 2B</xref>). Since females in X-linked DC have been previously described to have skewed X-inactivation,<xref ref-type="bibr" rid="b29">29</xref> <xref ref-type="bibr" rid="b30">30</xref> these data confirmed that the mutant gene in this family was on the X-chromosome.</p>
        <fig id="fig2" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Skewed X-inactivation in family 58 females and very short telomeres in affected individuals. (A) X-inactivation analysis of the androgen receptor locus in blood genomic DNA shows skewing in two females (IV.8 and IV.10, <xref ref-type="fig" rid="fig1">figure 1</xref>) compared to unrelated female controls. As expected, only a single allele is detected in genomic DNA from a male. Allele frequencies are compared with and without digestion with methylation specific restriction enzyme <italic>(HpaII)</italic> before PCR amplification. (B) X-inactivation analysis of genomic DNA from saliva from the same females also shows skewed ratios. (C) Lymphocyte telomere length of affected individuals are plotted by age relative to per cent normogram of healthy controls (n=400). Affected males have very short telomeres, at or less than the 1st centile, compared with age matched individuals. Carrier females also have telomere length near the 10th centile. Identifiers refer to pedigree position in <xref ref-type="fig" rid="fig1">figure 1</xref>. Males with known missense mutation Q31E also have very short telomeres by flow fluorescence in situ hybridisation (FISH).</p>
          </caption>
          <graphic xlink:href="jmedgenet85100fig2"/>
        </fig>
      </sec>
      <sec>
        <title>Dyskerin sequence is unaltered in family 58</title>
        <p>The <italic>DKC1</italic> gene is mutated in X-linked DC<xref ref-type="bibr" rid="b3">3</xref>; we therefore sequenced its 15 coding exons in the proband but did not identify variants. Since the disease gene was presumed haploid on the X-chromosome, this analysis also indicated that the proband did not carry a deletion in <italic>DKC1</italic>. To exclude a mutation that altered splicing, we generated lymphoblastoid lines from an affected male and amplified the <italic>DKC1</italic> cDNA. We identified no evidence of aberrant splicing or exon duplication. Therefore, the mutation that underlies inheritance in this X-linked DC family was not in the coding sequence and did not affect <italic>DKC1</italic> splicing.</p>
      </sec>
      <sec>
        <title>Affected individuals have short telomeres</title>
        <p>To confirm whether the clinical syndrome in this X-linked DC family is telomere mediated, we measured the telomere length. Lymphocyte telomere length identifies patients with germline defects due to telomerase dysfunction.<xref ref-type="bibr" rid="b19">19</xref> <xref ref-type="bibr" rid="b31">31</xref> <xref ref-type="bibr" rid="b32">32</xref> In four affected males, the telomere length was at or below the 1st centile compared to healthy age matched controls (p=0.009, paired t test, <xref ref-type="fig" rid="fig2">figure 2C</xref>). This range, which is three standard deviations below the mean, is diagnostic of an inherited mutation that affects telomerase or telomere maintenance. In a healthy male sibling, the telomere length was greater than the 50th centile (<xref ref-type="fig" rid="fig2">figure 2C</xref>). These data suggested that the inherited defect in this DC family affects telomere maintenance.</p>
      </sec>
      <sec>
        <title>Genome wide linkage identifies the <italic>DKC1</italic> locus</title>
        <p>The absence of a readily identifiable mutation in the <italic>DKC1</italic> gene and the presence of short telomeres suggested two main possibilities: either another gene on the X-chromosome which affects telomere maintenance underlies the inheritance in this family, or the DC features in this family can be attributed to a novel mechanism which affects dyskerin function. To begin to distinguish these, we performed linkage analysis on the X chromosome using SNP data from 16 individuals. Using an X-linked recessive model, we identified a single 47&#x2005;cM peak on Xq28 with a maximum log of the odds ratio (LOD) score of 3.25 (<xref ref-type="fig" rid="fig3">figure 3</xref>, supplementary table 4). The remainder of the X chromosome was not involved as the LOD score was less than &#x2212;2. This linkage peak flanked and contained the genomic locus for dyskerin (<xref ref-type="fig" rid="fig3">figure 3</xref>). We examined bioinformatically the 134 protein coding genes that fell within the linkage peak and found that only <italic>DKC1</italic> had been previously implicated in telomere maintenance. However, several genes of unknown function were also present under the linkage peak. A list of the protein coding genes is listed in supplementary table 5. Therefore, although the <italic>DKC1</italic> sequence was intact, an inherited mutation affecting the <italic>DKC1</italic> locus was responsible for the inheritance of the disease phenotype.</p>
        <fig id="fig3" position="float">
          <label>Figure 3</label>
          <caption>
            <p>X-chromosome linkage analysis points to the <italic>DKC1</italic> locus. Log of the odds ratio (LOD) score plot across the X-chromosome demonstrates linkage to Xq with a maximum LOD score of 3.25. The linkage peak includes the gene for dyskerin, <italic>DKC1</italic>, at Xq28.</p>
          </caption>
          <graphic xlink:href="jmedgenet85100fig3"/>
        </fig>
      </sec>
      <sec>
        <title>Affected individuals have reduced telomerase RNA levels</title>
        <p>Dyskerin is a box H/ACA protein and is essential for hTR stability and biogenesis.<xref ref-type="bibr" rid="b5">5</xref> <xref ref-type="bibr" rid="b7">7</xref> In patients with point mutations in <italic>DKC1</italic>, low hTR levels cause telomere shortening and telomere mediated disease.<xref ref-type="bibr" rid="b7">7</xref> Since our linkage study suggested that a mutation that affects <italic>DKC1</italic> may underlie the inheritance in this DC family, we tested whether affected individuals have low hTR levels. We quantified hTR in cells from affected males and compared them to healthy controls using quantitative real time PCR. We found hTR levels were 25% of control levels (p=0.043, Student t test, <xref ref-type="fig" rid="fig4">figure 4A</xref>). hTR levels were also decreased in cells from DC patients who carried a known missense dyskerin mutation (Q31E), as previously shown.<xref ref-type="bibr" rid="b8">8</xref> We examined but did not detect a difference in U23 and U64, two H/ACA snoRNAs. There was also no significant difference in the levels of U3, a member of the box C/D snoRNA family (<xref ref-type="fig" rid="fig4">figure 4B</xref>). These data suggested that the primary defect in this family causes telomere shortening, by decreasing hTR stability.</p>
        <fig id="fig4" position="float">
          <label>Figure 4</label>
          <caption>
            <p>Telomerase RNA and dyskerin protein levels are compromised in affected males. (A) Quantitative reverse transcription PCR (qRT-PCR) of hTR shows decreased levels in affected males compared with controls. hTR levels are also decreased in cells with a dyskerin Q31E missense mutation, as was previously shown. (B) Quantitation of snoRNAs (two box h/ACA and one box C/D) shows no change between affected individuals and controls. qRT-PCR data were normalised relative to ARF3 levels. (C) Representative grey scale Western blot image of one of the near-infrared colour fluorescent images used for quantitation. Molecular weight standard is shown on the left (kDa). Dyskerin appears at the expected size of 58&#x2005;kDa in affected individuals designated with &#x2018;A&#x2019; and controls designated &#x2018;C,&#x2019; as well as Hela cells. Lane 10 contains protein extract from a healthy male from family 58 who has long telomeres (pedigree ID V.3, <xref ref-type="fig" rid="fig1">figure 1</xref>). A total of 10&#x2005;&#x3BC;g of protein was loaded in each lane. (D) Quantitation of near-infrared fluorescence intensity from five independent experiments including the gel shown in (C) shows decreased dyskerin levels in affected males compared with controls. Each experiment contained control cells (n=5&#x2013;7), affected individuals (n=3&#x2013;4), and Q31E mutation carriers (n=2). Studies shown here used RNA and protein extracted from early passage lymphoblastoid lines (passage 1&#x2013;5). Means were compared using the Student t test. Error bars represent SE of the mean, and p values are two sided.</p>
          </caption>
          <graphic xlink:href="jmedgenet85100fig4"/>
        </fig>
      </sec>
      <sec>
        <title>Dyskerin protein levels are decreased</title>
        <p>Since the linkage analysis along with decreased hTR levels suggested that the <italic>DKC1</italic> gene locus contained the culprit defect, we tested whether a decrease in dyskerin protein levels may underlie the telomere shortening in this pedigree. We measured dyskerin levels by Western blot using a sensitive near-infrared fluorescence detection method.<xref ref-type="bibr" rid="b33">33</xref> Total protein extracted from lymphoblastoid cells from clinically affected members contained the expected 58&#x2005;kDa product identical to Hela cells and controls (representative image, <xref ref-type="fig" rid="fig4">figure 4C</xref>). However, in males who had short telomeres, dyskerin protein levels were significantly decreased relative to actin. In five independent experiments, we detected a decrease in dyskerin levels with a mean 67% of controls (range 52&#x2013;72%, p&lt;0.0001, Student t test, <xref ref-type="fig" rid="fig4">figure 4D</xref>). The dyskerin protein levels in males were also lower compared to a healthy related male with long telomeres (<xref ref-type="fig" rid="fig4">figure 4C</xref>). Our data indicated that decreased dyskerin protein levels contributed to the telomere shortening in this family.</p>
      </sec>
      <sec>
        <title>Examining <italic>DKC1</italic> transcriptional regulatory elements</title>
        <p>The decrease in dyskerin protein levels in the presence of an intact coding and cDNA sequence raised the possibility that a mutation that might affect proximal <italic>DKC1</italic> regulatory elements underlies the genetic defect. However, quantitation of <italic>DKC1</italic> expression using two independent primer sets was intact (supplementary figure 1). Nonetheless, to test this possibility, we amplified the 5&#x2032; upstream sequences which include the promoter (0.8&#x2005;kb), as well as the 3&#x2032; UTR (0.8&#x2005;kb), but found no variants. To determine whether regulatory elements may be located near dyskerin, we aligned mammalian <italic>DKC1</italic> sequences. Based on conservation algorithms available (phastCons, <ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu">http://genome.ucsc.edu</ext-link>), we found no conserved elements in non-coding regions, and prediction programs did not identify putative enhancers or transcription factor binding sites (Vista Enhancers and Yale TFBS, <ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu">http://genome.ucsc.edu</ext-link>, supplementary figure 2). Insulator prediction programs predicted an insulator element within intron 1 (<ext-link ext-link-type="uri" xlink:href="http://insulatordb.uthsc.edu/">http://insulatordb.uthsc.edu/</ext-link>), but sequencing of both introns 1 and 2 did not reveal variants from reference. The sequences of snoRNAs (<italic>SNORA36a</italic> and <italic>SNORA56</italic>) within introns 8 and 12 were also intact. To determine if more remote elements were involved, we amplified and sequenced the 11.6&#x2005;kb upstream and 1&#x2005;kb downstream intergenic sequences (supplementary figure 2), but found no deviations from reference sequence with the exception of a G to A transition, 7.8&#x2005;kb upstream of dyskerin, within a long interspersed nuclear element (LINE). This is the only sequence variant we identified in the proband near the <italic>DKC1</italic> gene. We also considered the possibility that a balanced translocation that disrupted the regulatory element may underlie the phenotype in this family, but metaphase FISH with X-chromosome specific probes did not reveal a micro-translocation. These data suggested that a micro-translocation larger than the resolution of metaphase FISH probes (1&#x2013;3&#x2005;Mb) is not likely.<xref ref-type="bibr" rid="b34">34</xref> Altogether, the intact expression of <italic>DKC1</italic>, along with the absence of readily identifiable variants in known regulatory elements, suggested that a potentially novel mechanism that controls dyskerin protein levels is defective in this family.</p>
      </sec>
      <sec>
        <title>Carrier females have short telomeres and mild DC features</title>
        <p>We next examined the clinical phenotypes in carrier females where attenuated disease features are known to occur in X-linked disorders.<xref ref-type="bibr" rid="b35">35</xref> We identified nail ridging characteristic of DC in one of four female carriers examined (<xref ref-type="fig" rid="fig5">figure 5A</xref>). Female carriers also had telomere lengths that were shorter than the 50th centile of controls (n=4, p=0.022, paired t test, <xref ref-type="fig" rid="fig2">figure 2C</xref>). Since telomere length is inherited,<xref ref-type="bibr" rid="b36">36</xref> these data suggested that telomere shortening may contribute to the low penetrance dyskeratosis phenotype in some carrier females.</p>
        <fig id="fig5" position="float">
          <label>Figure 5</label>
          <caption>
            <p>Clinical features of affected members. (A) Dystrophic nail changes with typical ridging of dyskeratosis congenita (DC) are shown in this photomicrograph of a female carrier. The telomere length for this individual is shown in <xref ref-type="fig" rid="fig2">figure 2C</xref>. (B) Nail dystrophy in an affected male child with very short telomeres in <xref ref-type="fig" rid="fig2">figure 2C</xref>. (C) Lung biopsy from the proband shows changes of bronchiolitis obliterans organising pneumonia and usual interstitial pneumonia patterns typical of idiopathic pulmonary fibrosis. (D) Biopsy from another affected individual (III.10) shows late stage idiopathic pulmonary fibrosis changes of bronchiolitis obliterans organising pneumonia and usual interstitial pneumonia. Subject gave informed consent for this study which included permission to publish clinical images.</p>
          </caption>
          <graphic xlink:href="jmedgenet85100fig5"/>
        </fig>
      </sec>
      <sec>
        <title>Prominent pulmonary and liver phenotypes in DC kindred</title>
        <p>To determine the spectrum of telomere mediated disease associated with decreased dyskerin levels, we carefully examined the clinical phenotype. In several young males, nail dystrophy was the first manifestation and was evident by the age of 15 (<xref ref-type="fig" rid="fig5">figure 5B</xref> and supplementary table 3). In the two cases where pulmonary fibrosis was biopsy proven, there was evidence of usual interstitial pneumonia as well as bronchiolitis obliterans organising pneumonia, a histologic manifestation which sometimes accompanies idiopathic pulmonary fibrosis (<xref ref-type="fig" rid="fig5">figure 5C,D</xref>). Both patients had honeycomb changes radiographically, did not respond to steroids, and died from their lung disease. These cases confirm prior observations suggesting that other interstitial lung disease histopathologies may co-exist in the same individual or within the same family along with usual interstitial pneumonia, and are manifestations of the same underlying genetic process.<xref ref-type="bibr" rid="b19">19</xref> <xref ref-type="bibr" rid="b37">37</xref> Although aplastic anaemia and cytopenias occur in &gt;85% of patients with classic features of DC,<xref ref-type="bibr" rid="b1">1</xref> <xref ref-type="bibr" rid="b38">38</xref> a detailed medical records review from 12 affected individuals did not reveal evidence of bone marrow failure. The data suggested that patients with classic DC can have their most prominent complications in the lung, and that these manifestations are sufficient to cause life threatening disease in the absence of bone marrow failure.</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>In this study, we identify decreased dyskerin protein levels as a novel mechanism of disease in X-linked DC. In affected individuals, despite the presence of an intact coding sequence, decreased dyskerin levels were associated with reduced hTR stability and telomere shortening. Knockdown of dyskerin levels has been previously shown to decrease hTR levels in cancer cell lines,<xref ref-type="bibr" rid="b39">39</xref> <xref ref-type="bibr" rid="b40">40</xref> although its consequences on telomere length have not been examined. Our data indicate that intact dyskerin levels, and not only protein sequence, are essential for in vivo telomere maintenance, and this defect is sufficient to cause premature mortality due to telomere mediated disease. In half of X-linked DC families, the mechanism of disease is not known. Our data, if replicated in larger cohorts, would suggest that quantitation of dyskerin protein levels can complement sequencing of the <italic>DKC1</italic> gene, and decreased levels of dyskerin, measured by sensitive methods, can identify male carrier status in a subset of genetically uncharacterised families.</p>
      <p>Our family study highlights the high penetrance of pulmonary disease in patients with classic features of DC. Traditionally, DC has been associated with premature mortality from bone marrow failure.<xref ref-type="bibr" rid="b41">41</xref> <xref ref-type="bibr" rid="b42">42</xref> Recent studies showing that mutations in <italic>hTERT</italic> and <italic>hTR</italic> have their most common manifestations in the lung (reviewed by Armanios<xref ref-type="bibr" rid="b13">13</xref>), along with the findings in this study, suggest that the penetrance of pulmonary phenotypes in families with DC may have been underestimated. In a DC registry where probands were recruited based on the classic mucocutaneous features, 20% of patients had pulmonary disease.<xref ref-type="bibr" rid="b1">1</xref> Our study indicates that, in the absence bone marrow failure, pulmonary and liver disease can be primary causes of mortality in some DC families. Similar to autosomal dominant families with mutations in <italic>hTERT</italic> or <italic>hTR</italic>, the median age of death due to pulmonary disease was older (39&#x2005;years), nearly two decades later than bone marrow failure onset in DC registries.<xref ref-type="bibr" rid="b19">19</xref> <xref ref-type="bibr" rid="b41">41</xref> These observations underscore the heterogeneity of DC phenotypes, and the fact that pulmonary disease may represent an attenuated, adult onset telomere phenotype which manifests rarely in individuals younger than the age of 20&#x2005;years. These patterns have important clinical implications as DC patients should be rigorously counselled against tobacco exposure, and iatrogenic pulmonary toxins should be avoided because of the known high rate of complications.<xref ref-type="bibr" rid="b43">43</xref> Although in our study female carriers were clinically unaffected except for the presence of nail dystrophy, it is possible the short telomeres they carry may be associated with an increased risk of developing telomere mediated disease, especially later in life. Future studies are needed in this area.</p>
      <p>How do we explain the observation that, in this family, affected males had decreased dyskerin protein and hTR levels, yet no change in <italic>DKC1</italic> mRNA levels? Several possibilities may account for this. MicroRNAs (miRNAs) are post-transcriptional regulators of protein levels.<xref ref-type="bibr" rid="b44">44</xref> It is theoretically possible that this family harbours a gain-of-function miRNA mutation that accounts for this observation. Disease causing germline mutations in miRNAs have been hypothesised, but to our knowledge, have not yet been shown to cause Mendelian disease.<xref ref-type="bibr" rid="b45">45</xref> In the linkage peak, there are 32 predicted miRNAs genes (listed in supplementary table 5) which are potential candidates. Regulatory RNAs known as large intergenic non-coding RNAs (lincRNAs) have also been recently shown to regulate protein levels directly, and it is possible that a mutation that affects these genes would alter dyskerin levels.<xref ref-type="bibr" rid="b46">46</xref> No lincRNAs have been heretofore identified within our linkage peak. Another alternative explanation is that a loss-of-function mutation in a protein coding gene that has a yet-to-be identified function in telomere biology underlies the decreased dyskerin levels. Several biochemical studies have examined the dyskerin interacting proteins,<xref ref-type="bibr" rid="b47 b48 b49">47&#x2013;49</xref> but none of them are identifiable as one of the protein genes that fall under the linkage peak in this family. Examining these possibilities in future studies could lead to important insights into the relevant genetic determinants of telomere length and age related disease in humans.</p>
      <p>Although we identified significant decreases in hTR associated with lower dyskerin levels, we did not identify a compromise in the H/ACA snoRNA levels we examined. Our data are similar to prior studies which did not identify decreases in snoRNA levels in cells from patients with <italic>DKC1</italic> missense mutations.<xref ref-type="bibr" rid="b7">7</xref> <xref ref-type="bibr" rid="b8">8</xref> These data differ from those in mouse cells where <italic>DKC1</italic> mutations were associated with a decrease in snoRNA levels.<xref ref-type="bibr" rid="b9 b10 b11">9&#x2013;11</xref> The contrast between human and mouse studies suggests that in human cells, hTR levels may be more sensitive to dyskerin dose fluctuation than snoRNAs.</p>
      <p>In summary, intact dyskerin levels are critical for hTR stability and in vivo telomere maintenance. A decrease in dyskerin protein, in the absence of coding mutations, is associated with a spectrum of telomere mediated disease which clinically manifests as familial pulmonary fibrosis and DC. If replicated in other families, careful quantitation of dyskerin protein levels may be useful for identifying male carrier status in uncharacterised X-linked DC families.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>We are grateful to all the family members who participated in this study. This work was supported by funding from the National Institutes of Health (K08CA118416) and the Doris Duke Charitable Foundation (to MA). EMP received support from an NHLBI supplement to Medical Scientist Training Program Award T32GM007309.</p>
    </ack>
    <fn-group>
      <fn fn-type="financial-disclosure">
        <p><bold>Funding:</bold><?release-delay 0|0 ?>Other Funders: NIH; <funding-source>Doris Duke Foundation</funding-source>.</p>
      </fn>
      <fn fn-type="other">
        <p><bold>Patient consent:</bold> Obtained.</p>
      </fn>
      <fn fn-type="other">
        <p><bold>Ethics approval:</bold> Approval was provided from both the Johns Hopkins and Vanderbilt University School of Medicine's Institutional Review Boards.</p>
      </fn>
      <fn fn-type="other">
        <p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="b1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirwan</surname><given-names>M</given-names></name><name><surname>Dokal</surname><given-names>I</given-names></name></person-group><article-title>Dyskeratosis congenita: a genetic disorder of many faces</article-title>. <source>Clin Genet</source><year>2008</year>;<volume>73</volume>:<fpage>103</fpage>&#x2013;<lpage>12</lpage><pub-id pub-id-type="pmid">18005359</pub-id></mixed-citation>
      </ref>
      <ref id="b2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savage</surname><given-names>SA</given-names></name><name><surname>Dokal</surname><given-names>I</given-names></name><name><surname>Armanios</surname><given-names>M</given-names></name><name><surname>Aubert</surname><given-names>G</given-names></name><name><surname>Cowen</surname><given-names>EW</given-names></name><name><surname>Domingo</surname><given-names>DL</given-names></name><name><surname>Giri</surname><given-names>N</given-names></name><name><surname>Greene</surname><given-names>MH</given-names></name><name><surname>Orchard</surname><given-names>PJ</given-names></name><name><surname>Tolar</surname><given-names>J</given-names></name><name><surname>Tsilou</surname><given-names>E</given-names></name><name><surname>Van Waes</surname><given-names>C</given-names></name><name><surname>Wong</surname><given-names>JM</given-names></name><name><surname>Young</surname><given-names>NS</given-names></name><name><surname>Alter</surname><given-names>BP</given-names></name></person-group><article-title>Dyskeratosis congenita: the first NIH clinical research workshop</article-title>. <source>Pediatr Blood Cancer</source><year>2009</year>;<volume>53</volume>:<fpage>520</fpage>&#x2013;<lpage>3</lpage><pub-id pub-id-type="pmid">19415736</pub-id></mixed-citation>
      </ref>
      <ref id="b3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heiss</surname><given-names>NS</given-names></name><name><surname>Knight</surname><given-names>SW</given-names></name><name><surname>Vulliamy</surname><given-names>TJ</given-names></name><name><surname>Klauck</surname><given-names>SM</given-names></name><name><surname>Wiemann</surname><given-names>S</given-names></name><name><surname>Mason</surname><given-names>PJ</given-names></name><name><surname>Poustka</surname><given-names>A</given-names></name><name><surname>Dokal</surname><given-names>I</given-names></name></person-group><article-title>X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions</article-title>. <source>Nat Genet</source><year>1998</year>;<volume>19</volume>:<fpage>32</fpage>&#x2013;<lpage>8</lpage><pub-id pub-id-type="pmid">9590285</pub-id></mixed-citation>
      </ref>
      <ref id="b4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname><given-names>SW</given-names></name><name><surname>Vulliamy</surname><given-names>TJ</given-names></name><name><surname>Morgan</surname><given-names>B</given-names></name><name><surname>Devriendt</surname><given-names>K</given-names></name><name><surname>Mason</surname><given-names>PJ</given-names></name><name><surname>Dokal</surname><given-names>I</given-names></name></person-group><article-title>Identification of novel DKC1 mutations in patients with dyskeratosis congenita: implications for pathophysiology and diagnosis</article-title>. <source>Hum Genet</source><year>2001</year>;<volume>108</volume>:<fpage>299</fpage>&#x2013;<lpage>303</lpage><pub-id pub-id-type="pmid">11379875</pub-id></mixed-citation>
      </ref>
      <ref id="b5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meier</surname><given-names>UT</given-names></name></person-group><article-title>The many facets of H/ACA ribonucleoproteins</article-title>. <source>Chromosoma</source><year>2005</year>;<volume>114</volume>:<fpage>1</fpage>&#x2013;<lpage>14</lpage><pub-id pub-id-type="pmid">15770508</pub-id></mixed-citation>
      </ref>
      <ref id="b6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>JR</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Collins</surname><given-names>K</given-names></name></person-group><article-title>A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3&#x2032; end</article-title>. <source>Mol Cell Biol</source><year>1999</year>;<volume>19</volume>:<fpage>567</fpage>&#x2013;<lpage>76</lpage><pub-id pub-id-type="pmid">9858580</pub-id></mixed-citation>
      </ref>
      <ref id="b7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>JR</given-names></name><name><surname>Wood</surname><given-names>E</given-names></name><name><surname>Collins</surname><given-names>K</given-names></name></person-group><article-title>A telomerase component is defective in the human disease dyskeratosis congenita</article-title>. <source>Nature</source><year>1999</year>;<volume>402</volume>:<fpage>551</fpage>&#x2013;<lpage>5</lpage><pub-id pub-id-type="pmid">10591218</pub-id></mixed-citation>
      </ref>
      <ref id="b8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>JM</given-names></name><name><surname>Kyasa</surname><given-names>MJ</given-names></name><name><surname>Hutchins</surname><given-names>L</given-names></name><name><surname>Collins</surname><given-names>K</given-names></name></person-group><article-title>Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita</article-title>. <source>Hum Genet</source><year>2004</year>;<volume>115</volume>:<fpage>448</fpage>&#x2013;<lpage>55</lpage><pub-id pub-id-type="pmid">15349768</pub-id></mixed-citation>
      </ref>
      <ref id="b9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruggero</surname><given-names>D</given-names></name><name><surname>Grisendi</surname><given-names>S</given-names></name><name><surname>Piazza</surname><given-names>F</given-names></name><name><surname>Rego</surname><given-names>E</given-names></name><name><surname>Mari</surname><given-names>F</given-names></name><name><surname>Rao</surname><given-names>PH</given-names></name><name><surname>Cordon-Cardo</surname><given-names>C</given-names></name><name><surname>Pandolfi</surname><given-names>PP</given-names></name></person-group><article-title>Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification</article-title>. <source>Science</source><year>2003</year>;<volume>299</volume>:<fpage>259</fpage>&#x2013;<lpage>62</lpage><pub-id pub-id-type="pmid">12522253</pub-id></mixed-citation>
      </ref>
      <ref id="b10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>J</given-names></name><name><surname>Crosby</surname><given-names>SD</given-names></name><name><surname>Heinz</surname><given-names>ME</given-names></name><name><surname>Bessler</surname><given-names>M</given-names></name><name><surname>Mason</surname><given-names>PJ</given-names></name></person-group><article-title>SnoRNA microarray analysis reveals changes in H/ACA and C/D RNA levels caused by dyskerin ablation in mouse liver</article-title>. <source>Biochem J</source><year>2010</year>;<volume>429</volume>:<fpage>33</fpage>&#x2013;<lpage>41</lpage><pub-id pub-id-type="pmid">20423331</pub-id></mixed-citation>
      </ref>
      <ref id="b11">
        <label>11</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>J</given-names></name><name><surname>Rudnick</surname><given-names>DA</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Crimmins</surname><given-names>DL</given-names></name><name><surname>Ladenson</surname><given-names>JH</given-names></name><name><surname>Bessler</surname><given-names>M</given-names></name><name><surname>Mason</surname><given-names>PJ</given-names></name></person-group><article-title>Dyskerin ablation in mouse liver inhibits rRNA processing and cell division</article-title>. <source>Mol Cell Biol</source><volume>30</volume>:<fpage>413</fpage>&#x2013;<lpage>22</lpage><pub-id pub-id-type="pmid">19917719</pub-id></mixed-citation>
      </ref>
      <ref id="b12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>JM</given-names></name><name><surname>Collins</surname><given-names>K</given-names></name></person-group><article-title>Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita</article-title>. <source>Genes Dev</source><year>2006</year>;<volume>20</volume>:<fpage>2848</fpage>&#x2013;<lpage>58</lpage><pub-id pub-id-type="pmid">17015423</pub-id></mixed-citation>
      </ref>
      <ref id="b13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armanios</surname><given-names>M</given-names></name></person-group><article-title>Syndromes of telomere shortening</article-title>. <source>Annu Rev Genomics Hum Genet</source><year>2009</year>;<volume>10</volume>:<fpage>45</fpage>&#x2013;<lpage>61</lpage><pub-id pub-id-type="pmid">19405848</pub-id></mixed-citation>
      </ref>
      <ref id="b14">
        <label>14</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vulliamy</surname><given-names>T</given-names></name><name><surname>Marrone</surname><given-names>A</given-names></name><name><surname>Goldman</surname><given-names>F</given-names></name><name><surname>Dearlove</surname><given-names>A</given-names></name><name><surname>Bessler</surname><given-names>M</given-names></name><name><surname>Mason</surname><given-names>PJ</given-names></name><name><surname>Dokal</surname><given-names>I</given-names></name></person-group><article-title>The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita</article-title>. <source>Nature</source><year>2001</year>;<volume>413</volume>:<fpage>432</fpage>&#x2013;<lpage>5</lpage><pub-id pub-id-type="pmid">11574891</pub-id></mixed-citation>
      </ref>
      <ref id="b15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armanios</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>JL</given-names></name><name><surname>Chang</surname><given-names>YP</given-names></name><name><surname>Brodsky</surname><given-names>RA</given-names></name><name><surname>Hawkins</surname><given-names>A</given-names></name><name><surname>Griffin</surname><given-names>CA</given-names></name><name><surname>Eshleman</surname><given-names>JR</given-names></name><name><surname>Cohen</surname><given-names>AR</given-names></name><name><surname>Chakravarti</surname><given-names>A</given-names></name><name><surname>Hamosh</surname><given-names>A</given-names></name><name><surname>Greider</surname><given-names>CW</given-names></name></person-group><article-title>Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita</article-title>. <source>Proc Natl Acad Sci U S A</source><year>2005</year>;<volume>102</volume>:<fpage>15960</fpage>&#x2013;<lpage>4</lpage><pub-id pub-id-type="pmid">16247010</pub-id></mixed-citation>
      </ref>
      <ref id="b16">
        <label>16</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fogarty</surname><given-names>PF</given-names></name><name><surname>Yamaguchi</surname><given-names>H</given-names></name><name><surname>Wiestner</surname><given-names>A</given-names></name><name><surname>Baerlocher</surname><given-names>GM</given-names></name><name><surname>Sloand</surname><given-names>E</given-names></name><name><surname>Zeng</surname><given-names>WS</given-names></name><name><surname>Read</surname><given-names>EJ</given-names></name><name><surname>Lansdorp</surname><given-names>PM</given-names></name><name><surname>Young</surname><given-names>NS</given-names></name></person-group><article-title>Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA</article-title>. <source>Lancet</source><year>2003</year>;<volume>362</volume>:<fpage>1628</fpage>&#x2013;<lpage>30</lpage><pub-id pub-id-type="pmid">14630445</pub-id></mixed-citation>
      </ref>
      <ref id="b17">
        <label>17</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savage</surname><given-names>SA</given-names></name><name><surname>Giri</surname><given-names>N</given-names></name><name><surname>Baerlocher</surname><given-names>GM</given-names></name><name><surname>Orr</surname><given-names>N</given-names></name><name><surname>Lansdorp</surname><given-names>PM</given-names></name><name><surname>Alter</surname><given-names>BP</given-names></name></person-group><article-title>TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita</article-title>. <source>Am J Hum Genet</source><year>2008</year>;<volume>82</volume>:<fpage>501</fpage>&#x2013;<lpage>9</lpage><pub-id pub-id-type="pmid">18252230</pub-id></mixed-citation>
      </ref>
      <ref id="b18">
        <label>18</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walne</surname><given-names>AJ</given-names></name><name><surname>Vulliamy</surname><given-names>T</given-names></name><name><surname>Beswick</surname><given-names>R</given-names></name><name><surname>Kirwan</surname><given-names>M</given-names></name><name><surname>Dokal</surname><given-names>I</given-names></name></person-group><article-title>TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes</article-title>. <source>Blood</source><year>2008</year>;<volume>112</volume>:<fpage>3594</fpage>&#x2013;<lpage>600</lpage><pub-id pub-id-type="pmid">18669893</pub-id></mixed-citation>
      </ref>
      <ref id="b19">
        <label>19</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armanios</surname><given-names>MY</given-names></name><name><surname>Chen</surname><given-names>JJ</given-names></name><name><surname>Cogan</surname><given-names>JD</given-names></name><name><surname>Alder</surname><given-names>JK</given-names></name><name><surname>Ingersoll</surname><given-names>RG</given-names></name><name><surname>Markin</surname><given-names>C</given-names></name><name><surname>Lawson</surname><given-names>WE</given-names></name><name><surname>Xie</surname><given-names>M</given-names></name><name><surname>Vulto</surname><given-names>I</given-names></name><name><surname>Phillips</surname><given-names>JA</given-names><suffix>3rd</suffix></name><name><surname>Lansdorp</surname><given-names>PM</given-names></name><name><surname>Greider</surname><given-names>CW</given-names></name><name><surname>Loyd</surname><given-names>JE</given-names></name></person-group><article-title>Telomerase mutations in families with idiopathic pulmonary fibrosis</article-title>. <source>N Engl J Med</source><year>2007</year>;<volume>356</volume>:<fpage>1317</fpage>&#x2013;<lpage>26</lpage><pub-id pub-id-type="pmid">17392301</pub-id></mixed-citation>
      </ref>
      <ref id="b20">
        <label>20</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penno</surname><given-names>MB</given-names></name><name><surname>Pedrotti-Krueger</surname><given-names>M</given-names></name><name><surname>Ray</surname><given-names>T</given-names></name></person-group><article-title>Cryopreservation of whole blood and isolated lymphocytes for B-cell transformation</article-title>. <source>J Tissue Cult Methods</source><year>1993</year>;<volume>15</volume>:<fpage>43</fpage>&#x2013;<lpage>8</lpage></mixed-citation>
      </ref>
      <ref id="b21">
        <label>21</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>RC</given-names></name><name><surname>Zoghbi</surname><given-names>HY</given-names></name><name><surname>Moseley</surname><given-names>AB</given-names></name><name><surname>Rosenblatt</surname><given-names>HM</given-names></name><name><surname>Belmont</surname><given-names>JW</given-names></name></person-group><article-title>Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X-chromosome inactivation</article-title>. <source>Am J Hum Genet</source><year>1992</year>;<volume>51</volume>:<fpage>1229</fpage>&#x2013;<lpage>39</lpage><pub-id pub-id-type="pmid">1281384</pub-id></mixed-citation>
      </ref>
      <ref id="b22">
        <label>22</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wigginton</surname><given-names>JE</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name></person-group><article-title>PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data</article-title>. <source>Bioinformatics</source><year>2005</year>;<volume>21</volume>:<fpage>3445</fpage>&#x2013;<lpage>7</lpage><pub-id pub-id-type="pmid">15947021</pub-id></mixed-citation>
      </ref>
      <ref id="b23">
        <label>23</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>JC</given-names></name><name><surname>Fry</surname><given-names>B</given-names></name><name><surname>Maller</surname><given-names>J</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name></person-group><article-title>Haploview: analysis and visualization of LD and haplotype maps</article-title>. <source>Bioinformatics</source><year>2005</year>;<volume>21</volume>:<fpage>263</fpage>&#x2013;<lpage>5</lpage><pub-id pub-id-type="pmid">15297300</pub-id></mixed-citation>
      </ref>
      <ref id="b24">
        <label>24</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Cherny</surname><given-names>SS</given-names></name><name><surname>Cookson</surname><given-names>WO</given-names></name><name><surname>Cardon</surname><given-names>LR</given-names></name></person-group><article-title>Merlin&#x2013;rapid analysis of dense genetic maps using sparse gene flow trees</article-title>. <source>Nat Genet</source><year>2002</year>;<volume>30</volume>:<fpage>97</fpage>&#x2013;<lpage>101</lpage><pub-id pub-id-type="pmid">11731797</pub-id></mixed-citation>
      </ref>
      <ref id="b25">
        <label>25</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cristofari</surname><given-names>G</given-names></name><name><surname>Lingner</surname><given-names>J</given-names></name></person-group><article-title>Telomere length homeostasis requires that telomerase levels are limiting</article-title>. <source>EMBO J</source><year>2006</year>;<volume>25</volume>:<fpage>565</fpage>&#x2013;<lpage>74</lpage><pub-id pub-id-type="pmid">16424902</pub-id></mixed-citation>
      </ref>
      <ref id="b26">
        <label>26</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romanova</surname><given-names>L</given-names></name><name><surname>Kellner</surname><given-names>S</given-names></name><name><surname>Katoku-Kikyo</surname><given-names>N</given-names></name><name><surname>Kikyo</surname><given-names>N</given-names></name></person-group><article-title>Novel role of nucleostemin in the maintenance of nucleolar architecture and integrity of small nucleolar ribonucleoproteins and the telomerase complex</article-title>. <source>J Biol Chem</source><year>2009</year>;<volume>284</volume>:<fpage>26685</fpage>&#x2013;<lpage>94</lpage><pub-id pub-id-type="pmid">19648109</pub-id></mixed-citation>
      </ref>
      <ref id="b27">
        <label>27</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsakiri</surname><given-names>KD</given-names></name><name><surname>Cronkhite</surname><given-names>JT</given-names></name><name><surname>Kuan</surname><given-names>PJ</given-names></name><name><surname>Xing</surname><given-names>C</given-names></name><name><surname>Raghu</surname><given-names>G</given-names></name><name><surname>Weissler</surname><given-names>JC</given-names></name><name><surname>Rosenblatt</surname><given-names>RL</given-names></name><name><surname>Shay</surname><given-names>JW</given-names></name><name><surname>Garcia</surname><given-names>CK</given-names></name></person-group><article-title>Adult-onset pulmonary fibrosis caused by mutations in telomerase</article-title>. <source>Proc Natl Acad Sci U S A</source><year>2007</year>;<volume>104</volume>:<fpage>7552</fpage>&#x2013;<lpage>7</lpage><pub-id pub-id-type="pmid">17460043</pub-id></mixed-citation>
      </ref>
      <ref id="b28">
        <label>28</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basel-Vanagaite</surname><given-names>L</given-names></name><name><surname>Dokal</surname><given-names>I</given-names></name><name><surname>Tamary</surname><given-names>H</given-names></name><name><surname>Avigdor</surname><given-names>A</given-names></name><name><surname>Garty</surname><given-names>BZ</given-names></name><name><surname>Volkov</surname><given-names>A</given-names></name><name><surname>Vulliamy</surname><given-names>T</given-names></name></person-group><article-title>Expanding the clinical phenotype of autosomal dominant dyskeratosis congenita caused by TERT mutations</article-title>. <source>Haematologica</source><year>2008</year>;<volume>93</volume>:<fpage>943</fpage>&#x2013;<lpage>4</lpage><pub-id pub-id-type="pmid">18460650</pub-id></mixed-citation>
      </ref>
      <ref id="b29">
        <label>29</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devriendt</surname><given-names>K</given-names></name><name><surname>Matthijs</surname><given-names>G</given-names></name><name><surname>Legius</surname><given-names>E</given-names></name><name><surname>Schollen</surname><given-names>E</given-names></name><name><surname>Blockmans</surname><given-names>D</given-names></name><name><surname>van Geet</surname><given-names>C</given-names></name><name><surname>Degreef</surname><given-names>H</given-names></name><name><surname>Cassiman</surname><given-names>JJ</given-names></name><name><surname>Fryns</surname><given-names>JP</given-names></name></person-group><article-title>Skewed X-chromosome inactivation in female carriers of dyskeratosis congenita</article-title>. <source>Am J Hum Genet</source><year>1997</year>;<volume>60</volume>:<fpage>581</fpage>&#x2013;<lpage>7</lpage><pub-id pub-id-type="pmid">9042917</pub-id></mixed-citation>
      </ref>
      <ref id="b30">
        <label>30</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vulliamy</surname><given-names>TJ</given-names></name><name><surname>Knight</surname><given-names>SW</given-names></name><name><surname>Dokal</surname><given-names>I</given-names></name><name><surname>Mason</surname><given-names>PJ</given-names></name></person-group><article-title>Skewed X-inactivation in carriers of X-linked dyskeratosis congenita</article-title>. <source>Blood</source><year>1997</year>;<volume>90</volume>:<fpage>2213</fpage>&#x2013;<lpage>16</lpage><pub-id pub-id-type="pmid">9310472</pub-id></mixed-citation>
      </ref>
      <ref id="b31">
        <label>31</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alter</surname><given-names>BP</given-names></name><name><surname>Baerlocher</surname><given-names>GM</given-names></name><name><surname>Savage</surname><given-names>SA</given-names></name><name><surname>Chanock</surname><given-names>SJ</given-names></name><name><surname>Weksler</surname><given-names>BB</given-names></name><name><surname>Willner</surname><given-names>JP</given-names></name><name><surname>Peters</surname><given-names>JA</given-names></name><name><surname>Giri</surname><given-names>N</given-names></name><name><surname>Lansdorp</surname><given-names>PM</given-names></name></person-group><article-title>Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita</article-title>. <source>Blood</source><year>2007</year>;<volume>110</volume>:<fpage>1439</fpage>&#x2013;<lpage>47</lpage><pub-id pub-id-type="pmid">17468339</pub-id></mixed-citation>
      </ref>
      <ref id="b32">
        <label>32</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alder</surname><given-names>JK</given-names></name><name><surname>Chen</surname><given-names>JJ</given-names></name><name><surname>Lancaster</surname><given-names>L</given-names></name><name><surname>Danoff</surname><given-names>S</given-names></name><name><surname>Su</surname><given-names>SC</given-names></name><name><surname>Cogan</surname><given-names>JD</given-names></name><name><surname>Vulto</surname><given-names>I</given-names></name><name><surname>Xie</surname><given-names>M</given-names></name><name><surname>Qi</surname><given-names>X</given-names></name><name><surname>Tuder</surname><given-names>RM</given-names></name><name><surname>Phillips</surname><given-names>JA</given-names><suffix>3rd</suffix></name><name><surname>Lansdorp</surname><given-names>PM</given-names></name><name><surname>Loyd</surname><given-names>JE</given-names></name><name><surname>Armanios</surname><given-names>MY</given-names></name></person-group><article-title>Short telomeres are a risk factor for idiopathic pulmonary fibrosis</article-title>. <source>Proc Natl Acad Sci U S A</source><year>2008</year>;<volume>105</volume>:<fpage>13051</fpage>&#x2013;<lpage>6</lpage><pub-id pub-id-type="pmid">18753630</pub-id></mixed-citation>
      </ref>
      <ref id="b33">
        <label>33</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathews</surname><given-names>ST</given-names></name><name><surname>Plaisance</surname><given-names>EP</given-names></name><name><surname>Kim</surname><given-names>T</given-names></name></person-group><article-title>Imaging systems for westerns: chemiluminescence vs. infrared detection</article-title>. <source>Methods Mol Biol</source><year>2009</year>;<volume>536</volume>:<fpage>499</fpage>&#x2013;<lpage>513</lpage><pub-id pub-id-type="pmid">19378087</pub-id></mixed-citation>
      </ref>
      <ref id="b34">
        <label>34</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menten</surname><given-names>B</given-names></name><name><surname>Maas</surname><given-names>N</given-names></name><name><surname>Thienpont</surname><given-names>B</given-names></name><name><surname>Buysse</surname><given-names>K</given-names></name><name><surname>Vandesompele</surname><given-names>J</given-names></name><name><surname>Melotte</surname><given-names>C</given-names></name><name><surname>de Ravel</surname><given-names>T</given-names></name><name><surname>Van Vooren</surname><given-names>S</given-names></name><name><surname>Balikova</surname><given-names>I</given-names></name><name><surname>Backx</surname><given-names>L</given-names></name><name><surname>Janssens</surname><given-names>S</given-names></name><name><surname>De Paepe</surname><given-names>A</given-names></name><name><surname>De Moor</surname><given-names>B</given-names></name><name><surname>Moreau</surname><given-names>Y</given-names></name><name><surname>Marynen</surname><given-names>P</given-names></name><name><surname>Fryns</surname><given-names>JP</given-names></name><name><surname>Mortier</surname><given-names>G</given-names></name><name><surname>Devriendt</surname><given-names>K</given-names></name><name><surname>Speleman</surname><given-names>F</given-names></name><name><surname>Vermeesch</surname><given-names>JR</given-names></name></person-group><article-title>Emerging patterns of cryptic chromosomal imbalance in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of published reports</article-title>. <source>J Med Genet</source><year>2006</year>;<volume>43</volume>:<fpage>625</fpage>&#x2013;<lpage>33</lpage><pub-id pub-id-type="pmid">16490798</pub-id></mixed-citation>
      </ref>
      <ref id="b35">
        <label>35</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Migeon</surname><given-names>BR</given-names></name></person-group><article-title>The role of X inactivation and cellular mosaicism in women's health and sex-specific diseases</article-title>. <source>JAMA</source><year>2006</year>;<volume>295</volume>:<fpage>1428</fpage>&#x2013;<lpage>33</lpage><pub-id pub-id-type="pmid">16551715</pub-id></mixed-citation>
      </ref>
      <ref id="b36">
        <label>36</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armanios</surname><given-names>M</given-names></name><name><surname>Alder</surname><given-names>JK</given-names></name><name><surname>Parry</surname><given-names>EM</given-names></name><name><surname>Karim</surname><given-names>B</given-names></name><name><surname>Strong</surname><given-names>MA</given-names></name><name><surname>Greider</surname><given-names>CW</given-names></name></person-group><article-title>Short telomeres are sufficient to cause the degenerative defects associated with aging</article-title>. <source>Am J Hum Genet</source><year>2009</year>;<volume>85</volume>:<fpage>823</fpage>&#x2013;<lpage>32</lpage><pub-id pub-id-type="pmid">19944403</pub-id></mixed-citation>
      </ref>
      <ref id="b37">
        <label>37</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cronkhite</surname><given-names>JT</given-names></name><name><surname>Xing</surname><given-names>C</given-names></name><name><surname>Raghu</surname><given-names>G</given-names></name><name><surname>Chin</surname><given-names>KM</given-names></name><name><surname>Torres</surname><given-names>F</given-names></name><name><surname>Rosenblatt</surname><given-names>RL</given-names></name><name><surname>Garcia</surname><given-names>CK</given-names></name></person-group><article-title>Telomere shortening in familial and sporadic pulmonary fibrosis</article-title>. <source>Am J Respir Crit Care Med</source><year>2008</year>;<volume>178</volume>:<fpage>729</fpage>&#x2013;<lpage>37</lpage><pub-id pub-id-type="pmid">18635888</pub-id></mixed-citation>
      </ref>
      <ref id="b38">
        <label>38</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname><given-names>S</given-names></name><name><surname>Vulliamy</surname><given-names>T</given-names></name><name><surname>Copplestone</surname><given-names>A</given-names></name><name><surname>Gluckman</surname><given-names>E</given-names></name><name><surname>Mason</surname><given-names>P</given-names></name><name><surname>Dokal</surname><given-names>I</given-names></name></person-group><article-title>Dyskeratosis Congenita (DC) Registry: identification of new features of DC</article-title>. <source>Br J Haematol</source><year>1998</year>;<volume>103</volume>:<fpage>990</fpage>&#x2013;<lpage>6</lpage><pub-id pub-id-type="pmid">9886310</pub-id></mixed-citation>
      </ref>
      <ref id="b39">
        <label>39</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montanaro</surname><given-names>L</given-names></name><name><surname>Brigotti</surname><given-names>M</given-names></name><name><surname>Clohessy</surname><given-names>J</given-names></name><name><surname>Barbieri</surname><given-names>S</given-names></name><name><surname>Ceccarelli</surname><given-names>C</given-names></name><name><surname>Santini</surname><given-names>D</given-names></name><name><surname>Taffurelli</surname><given-names>M</given-names></name><name><surname>Calienni</surname><given-names>M</given-names></name><name><surname>Teruya-Feldstein</surname><given-names>J</given-names></name><name><surname>Trere</surname><given-names>D</given-names></name><name><surname>Pandolfi</surname><given-names>PP</given-names></name><name><surname>Derenzini</surname><given-names>M</given-names></name></person-group><article-title>Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer</article-title>. <source>J Pathol</source><year>2006</year>;<volume>210</volume>:<fpage>10</fpage>&#x2013;<lpage>18</lpage><pub-id pub-id-type="pmid">16841302</pub-id></mixed-citation>
      </ref>
      <ref id="b40">
        <label>40</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montanaro</surname><given-names>L</given-names></name><name><surname>Calienni</surname><given-names>M</given-names></name><name><surname>Ceccarelli</surname><given-names>C</given-names></name><name><surname>Santini</surname><given-names>D</given-names></name><name><surname>Taffurelli</surname><given-names>M</given-names></name><name><surname>Pileri</surname><given-names>S</given-names></name><name><surname>Trere</surname><given-names>D</given-names></name><name><surname>Derenzini</surname><given-names>M</given-names></name></person-group><article-title>Relationship between dyskerin expression and telomerase activity in human breast cancer</article-title>. <source>Cell Oncol</source><year>2008</year>;<volume>30</volume>:<fpage>483</fpage>&#x2013;<lpage>90</lpage><pub-id pub-id-type="pmid">18936525</pub-id></mixed-citation>
      </ref>
      <ref id="b41">
        <label>41</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savage</surname><given-names>SA</given-names></name><name><surname>Alter</surname><given-names>BP</given-names></name></person-group><article-title>Dyskeratosis congenita</article-title>. <source>Hematol Oncol Clin North Am</source><year>2009</year>;<volume>23</volume>:<fpage>215</fpage>&#x2013;<lpage>31</lpage><pub-id pub-id-type="pmid">19327580</pub-id></mixed-citation>
      </ref>
      <ref id="b42">
        <label>42</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dokal</surname><given-names>I</given-names></name><name><surname>Vulliamy</surname><given-names>T</given-names></name></person-group><article-title>Dyskeratosis congenita: its link to telomerase and aplastic anaemia</article-title>. <source>Blood Rev</source><year>2003</year>;<volume>17</volume>:<fpage>217</fpage>&#x2013;<lpage>25</lpage><pub-id pub-id-type="pmid">14556776</pub-id></mixed-citation>
      </ref>
      <ref id="b43">
        <label>43</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yabe</surname><given-names>M</given-names></name><name><surname>Yabe</surname><given-names>H</given-names></name><name><surname>Hattori</surname><given-names>K</given-names></name><name><surname>Morimoto</surname><given-names>T</given-names></name><name><surname>Hinohara</surname><given-names>T</given-names></name><name><surname>Takakura</surname><given-names>I</given-names></name><name><surname>Shimizu</surname><given-names>T</given-names></name><name><surname>Shimamura</surname><given-names>K</given-names></name><name><surname>Tang</surname><given-names>X</given-names></name><name><surname>Kato</surname><given-names>S</given-names></name></person-group><article-title>Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation</article-title>. <source>Bone Marrow Transplant</source><year>1997</year>;<volume>19</volume>:<fpage>389</fpage>&#x2013;<lpage>92</lpage><pub-id pub-id-type="pmid">9051251</pub-id></mixed-citation>
      </ref>
      <ref id="b44">
        <label>44</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krol</surname><given-names>J</given-names></name><name><surname>Loedige</surname><given-names>I</given-names></name><name><surname>Filipowicz</surname><given-names>W</given-names></name></person-group><article-title>The widespread regulation of microRNA biogenesis, function and decay</article-title>. <source>Nat Rev Genet</source><year>2010</year>;<volume>11</volume>:<fpage>597</fpage>&#x2013;<lpage>610</lpage><pub-id pub-id-type="pmid">20661255</pub-id></mixed-citation>
      </ref>
      <ref id="b45">
        <label>45</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>TC</given-names></name><name><surname>Mendell</surname><given-names>JT</given-names></name></person-group><article-title>microRNAs in vertebrate physiology and human disease</article-title>. <source>Annu Rev Genomics Hum Genet</source><year>2007</year>;<volume>8</volume>:<fpage>215</fpage>&#x2013;<lpage>39</lpage><pub-id pub-id-type="pmid">17506656</pub-id></mixed-citation>
      </ref>
      <ref id="b46">
        <label>46</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guttman</surname><given-names>M</given-names></name><name><surname>Amit</surname><given-names>I</given-names></name><name><surname>Garber</surname><given-names>M</given-names></name><name><surname>French</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>MF</given-names></name><name><surname>Feldser</surname><given-names>D</given-names></name><name><surname>Huarte</surname><given-names>M</given-names></name><name><surname>Zuk</surname><given-names>O</given-names></name><name><surname>Carey</surname><given-names>BW</given-names></name><name><surname>Cassady</surname><given-names>JP</given-names></name><name><surname>Cabili</surname><given-names>MN</given-names></name><name><surname>Jaenisch</surname><given-names>R</given-names></name><name><surname>Mikkelsen</surname><given-names>TS</given-names></name><name><surname>Jacks</surname><given-names>T</given-names></name><name><surname>Hacohen</surname><given-names>N</given-names></name><name><surname>Bernstein</surname><given-names>BE</given-names></name><name><surname>Kellis</surname><given-names>M</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Rinn</surname><given-names>JL</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name></person-group><article-title>Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals</article-title>. <source>Nature</source><year>2009</year>;<volume>458</volume>:<fpage>223</fpage>&#x2013;<lpage>7</lpage><pub-id pub-id-type="pmid">19182780</pub-id></mixed-citation>
      </ref>
      <ref id="b47">
        <label>47</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>SB</given-names></name><name><surname>Graham</surname><given-names>ME</given-names></name><name><surname>Lovrecz</surname><given-names>GO</given-names></name><name><surname>Bache</surname><given-names>N</given-names></name><name><surname>Robinson</surname><given-names>PJ</given-names></name><name><surname>Reddel</surname><given-names>RR</given-names></name></person-group><article-title>Protein composition of catalytically active human telomerase from immortal cells</article-title>. <source>Science</source><year>2007</year>;<volume>315</volume>:<fpage>1850</fpage>&#x2013;<lpage>3</lpage><pub-id pub-id-type="pmid">17395830</pub-id></mixed-citation>
      </ref>
      <ref id="b48">
        <label>48</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venteicher</surname><given-names>AS</given-names></name><name><surname>Abreu</surname><given-names>EB</given-names></name><name><surname>Meng</surname><given-names>Z</given-names></name><name><surname>McCann</surname><given-names>KE</given-names></name><name><surname>Terns</surname><given-names>RM</given-names></name><name><surname>Veenstra</surname><given-names>TD</given-names></name><name><surname>Terns</surname><given-names>MP</given-names></name><name><surname>Artandi</surname><given-names>SE</given-names></name></person-group><article-title>A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis</article-title>. <source>Science</source><year>2009</year>;<volume>323</volume>:<fpage>644</fpage>&#x2013;<lpage>8</lpage><pub-id pub-id-type="pmid">19179534</pub-id></mixed-citation>
      </ref>
      <ref id="b49">
        <label>49</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venteicher</surname><given-names>AS</given-names></name><name><surname>Meng</surname><given-names>Z</given-names></name><name><surname>Mason</surname><given-names>PJ</given-names></name><name><surname>Veenstra</surname><given-names>TD</given-names></name><name><surname>Artandi</surname><given-names>SE</given-names></name></person-group><article-title>Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly</article-title>. <source>Cell</source><year>2008</year>;<volume>132</volume>:<fpage>945</fpage>&#x2013;<lpage>57</lpage><pub-id pub-id-type="pmid">18358808</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
